You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liposomal Grb-2 with LDAC for AML

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adult Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001, BP1001

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • +3 more
  • BP1001
  • BP1001 in combination with LDAC
  • Houston, Texas
    M. D. Anderson Cancer Center
May 26, 2020

Acute Myeloid Leukemia (AML) Trial in United States (BP1001 in combination with Ventoclax plus decitabine, BP1001 plus

Recruiting
  • Acute Myeloid Leukemia (AML)
  • BP1001 in combination with Ventoclax plus decitabine
  • BP1001 plus decitabine
  • Fairway, Kansas
  • +5 more
Jan 3, 2022

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022

Solid Tumor, Adult, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Houston (BP1001-A (Liposomal Grb2 Antisense

Not yet recruiting
  • Solid Tumor, Adult
  • +5 more
  • BP1001-A (Liposomal Grb2 Antisense Oligonucleotide)
  • BP1001-A (Liposomal Grb2 Antisense Oligonucleotide) with paclitaxel
  • (no location specified)
Jun 7, 2022

Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Bologna, Italy
  • +4 more
Jan 31, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (BP1002; Liposomal Bcl-2 Antisense

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide
  • Decitabine (in combination with BP1002)
  • (no location specified)
Mar 8, 2022

Leukemia, Myeloid, Acute Trial in United States (Liposomal Annamycin)

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • Liposomal Annamycin
  • La Jolla, California
  • +3 more
Feb 28, 2022

Leukemia, Myeloid, Acute Trial in Poland (Liposomal Annamycin)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Liposomal Annamycin
  • Poznań, Poland
  • +4 more
Apr 4, 2022

Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +6 more
Nov 16, 2022

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)

Suspended
  • Recurrent Acute Myeloid Leukemia
  • Enasidenib Mesylate
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Los Angeles, California
  • +3 more
Sep 27, 2022

Chronic Myelogenous Leukemia, Ph1-Positive, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001 (varying

Withdrawn
  • Chronic Myelogenous Leukemia, Ph1-Positive
  • +2 more
  • BP1001 (varying dose)
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
May 26, 2020

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • (no location specified)
Nov 8, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Acute Myeloid Leukemia (AML) Trial in Worldwide (Placebo, Venetoclax, Cytarabine)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia (AML)
  • Placebo
  • +2 more
  • Tampa, Florida
  • +108 more
Jul 15, 2022

Secondary Acute Myeloid Leukemia Trial in Houston (Cladribine, Cytarabine, Uproleselan)

Recruiting
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 25, 2021

Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Miami, Florida
    University of Miami
Dec 7, 2021

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))

Completed
  • AML
  • Cytarabine (Phase 1 only)
  • +3 more
  • Los Angeles, California
  • +16 more
Feb 22, 2022

Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Nagoya, Aichi, Japan
  • +8 more
Jan 12, 2022

Acute Myeloid Leukemia Trial in Worldwide (AZD1152, LDAC)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Atlanta, Georgia
  • +44 more
Feb 21, 2020

iN the Real Practice

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Vyxeos liposomal
  • Roma, Italy
    Policlinico Tor Vergata
Nov 16, 2023

Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • Jerusalem, Yerushalayim, Israel
    Shaare Zedek Medical Center
Oct 25, 2022

Leukemia, Myeloid, Acute, De Novo, Age More 60yr Trial in Spain (Azacitidine, Venetoclax, Quizartinib)

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • Alcalá De Henares, Spain
  • +14 more
May 17, 2021